AlphaYouCOAG: Walbert Keli discloses securities transactions
By AlphaYouPublished Form 4
Walbert Keli
Reporting filer
Walbert Keli reported Grant or award in Hemab Therapeutics Holdings, Inc.: 36000 units of Stock Option (Right to Buy) (derivative), dated 2026-09-24. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 25, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Walbert Keli | 2026-09-24 | A | Grant or award | 36000 | 0.00 | 36,000 | 1 day | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Walbert Keli
- Date
- 2026-09-24
- Code
- A
- Action
- Grant or award
- Quantity
- 36000
- Price
- 0.00
- Following holdings
- 36,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 35.72
- transaction Date: 2026-09-24
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 36000
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-09-23
- underlying Security Title: Common Stock
- underlying Security Shares: 36000
- shares Owned Following Transaction: 36000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Walbert Keli: Director.
- F1: This option was granted on September 24, 2026. The shares underlying the option are scheduled to vest over three years in equal monthly installments from September 24, 2026 through September 24, 2029, subject to continuous service.
Original sources
Prepared automatically from public filing data. Report a correction.